High expression of KIF14 is demonstrated to be a significant prognostic biomarker in various cancers, including pancreatic adenocarcinoma (PAAD), hepatocellular carcinoma, cervical cancer and ovarian cancer [16–19]. Here, KIF14 is linked to pancreatic adenocarcinoma.